plerixafor has been researched along with Allodynia in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, X; Li, L; Lu, Q; Xu, J; Yang, Z; Yi, S; Zhang, H; Zhao, J; Zhu, J | 1 |
| Chen, GZ; Li, M; Luo, WJ; Wu, XZ; Yang, F; Zou, YQ | 1 |
| Di, Y; Fan, N; Huang, X; Qu, L; Yu, Y | 1 |
| Fan, YH; Huang, SS; Li, F; Wei, L; Xue, ZY; Yuan, Y; Zhu, X | 1 |
| Adler, MW; Chen, X; Cowan, A; Doura, M; Eisenstein, TK; Geller, EB; Inan, S; Meissler, JJ; Rawls, SM; Tallarida, CS; Watson, MN | 1 |
| Abdel Mola, AF; Balfas, MA; Fahmi, MK; Hamed, EA; Makhlouf, MM; Mohamed Farghaly, HS | 1 |
| Cheung, CW; Chung, SK; Luo, X; Pan, Z; Sun, L; Tai, WL; Xia, Z | 1 |
| Chao, YC; Li, X; Wang, Y; Xie, F; Yue, Y | 1 |
| Li, XQ; Ma, H; Sun, XJ; Tan, WF; Zhang, ZL | 1 |
| Deng, L; Guindon, J; Hohmann, AG; Makriyannis, A; Thakur, GA; Vemuri, VK; White, FA | 1 |
10 other study(ies) available for plerixafor and Allodynia
| Article | Year |
|---|---|
Inhibition of CXCR4 in Spinal Cord and DRG with AMD3100 Attenuates Colon-Bladder Cross-Organ Sensitization.
Topics: Animals; Benzylamines; Colitis; Cyclams; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Female; Flavonoids; Ganglia, Spinal; Hyperalgesia; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, CXCR4; Signal Transduction; Spinal Cord; Urinary Bladder Diseases; Urination | 2022 |
Intervertebral foramen injection of plerixafor attenuates neuropathic pain after chronic compression of the dorsal root ganglion: Possible involvement of the down-regulation of Nav1.8 and Nav1.9.
Topics: Animals; Benzylamines; Cyclams; Down-Regulation; Ganglia, Spinal; Heterocyclic Compounds; Hyperalgesia; Male; Neuralgia; Quality of Life; Rats | 2021 |
Effect of CXCL12/CXCR4 signaling on neuropathic pain after chronic compression of dorsal root ganglion.
Topics: Animals; Benzylamines; Cells, Cultured; Chemokine CXCL12; Cyclams; Ganglia, Spinal; Heterocyclic Compounds; Hyperalgesia; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neuralgia; Neurons, Afferent; Pain Measurement; Receptors, CXCR4; Signal Transduction | 2017 |
Upregulation of CXCR4 through promoter demethylation contributes to inflammatory hyperalgesia in rats.
Topics: Animals; Benzylamines; Chromatin Immunoprecipitation; Cyclams; Demethylation; Freund's Adjuvant; Heterocyclic Compounds; Hyperalgesia; Inflammation; Male; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Receptors, CXCR4; RNA, Messenger; Up-Regulation | 2018 |
Chemokine receptor antagonists enhance the antinociceptive activity of oxycodone and meperidine on incisional pain in rats.
Topics: Analgesics, Opioid; Animals; Benzylamines; Cyclams; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Heterocyclic Compounds; Hyperalgesia; Male; Maraviroc; Meperidine; Oxycodone; Rats, Sprague-Dawley; Receptors, Chemokine | 2019 |
Role of monocyte chemoattractant protein-1, stromal derived factor-1 and retinoic acid in pathophysiology of neuropathic pain in rats.
Topics: Animals; Benzylamines; Chemokine CCL2; Chemokine CXCL12; Cyclams; Disease Models, Animal; Doxycycline; Female; Heterocyclic Compounds; Hyperalgesia; Neuralgia; Nociception; Pain Measurement; Pain Threshold; Rats; Rats, Wistar; Sciatic Nerve; Tretinoin | 2016 |
Crosstalk between astrocytic CXCL12 and microglial CXCR4 contributes to the development of neuropathic pain.
Topics: Animals; Benzylamines; Chemokine CXCL12; Cyclams; Disease Models, Animal; Heterocyclic Compounds; Hyperalgesia; Injections, Spinal; Ischemia; Ligation; Lumbar Vertebrae; Male; Mice, Inbred C57BL; Microglia; Models, Biological; Motor Activity; Neuralgia; Nociception; Pyridines; Rats; Receptors, CXCR4; Sciatic Nerve | 2016 |
Early Repeated Administration of CXCR4 Antagonist AMD3100 Dose-Dependently Improves Neuropathic Pain in Rats After L5 Spinal Nerve Ligation.
Topics: Analgesics, Opioid; Animals; Benzylamines; Cyclams; Disease Models, Animal; Heterocyclic Compounds; Hyperalgesia; Ligation; Male; Narcotic Antagonists; Neuralgia; Rats, Sprague-Dawley; Receptors, CXCR4; Spinal Cord; Spinal Nerves | 2016 |
Down-Regulation of CXCL12/CXCR4 Expression Alleviates Ischemia-Reperfusion-Induced Inflammatory Pain via Inhibiting Glial TLR4 Activation in the Spinal Cord.
Topics: Animals; Astrocytes; Behavior, Animal; Benzylamines; Chemokine CXCL12; Cyclams; Down-Regulation; Heterocyclic Compounds; Hyperalgesia; Inflammation; Microglia; Pain; Rats; Rats, Sprague-Dawley; Receptors, CXCR4; Reperfusion Injury; Spinal Cord; Sulfonamides; Toll-Like Receptor 4 | 2016 |
The maintenance of cisplatin- and paclitaxel-induced mechanical and cold allodynia is suppressed by cannabinoid CB₂ receptor activation and independent of CXCR4 signaling in models of chemotherapy-induced peripheral neuropathy.
Topics: Animals; Benzylamines; Chromones; Cisplatin; Cryopyrin-Associated Periodic Syndromes; Cyclams; Disease Models, Animal; Heterocyclic Compounds; Hyperalgesia; Indoles; Male; Paclitaxel; Peripheral Nervous System Diseases; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB2; Receptors, CXCR4; Signal Transduction; Time Factors; Treatment Outcome | 2012 |